Daniel Penaranda

Juvenile-onset recurrent respiratory papillomatosis (JORRP) is a rare but highly morbid disease resulting from mother-to-newborn transmission of human papillomavirus (HPV).1 Vaccines against HPV were introduced in the US in 2006. However, longitudinal data are limited on their implications for JORRP incidence. This study aimed to describe JORRP incidence in the US in this post–HPV vaccination era.

Methods This was an observational, cross-sectional, analytical study conducted during February-March 2021 in which conventional pure-tone audiometry (0.25–8 kHz) and EHFA (9–20 kHz) were performed in Afro-Colombian adolescents aged 13–17 years from Isla Barú, Colombia. Sociodemographic and risk factor questionnaires were applied to assess probable factors associated with acquired EHF hearing loss.